Gen-Probe was a company based in San Diego, California specializing in Clinical Diagnostics, Blood Screening, Transplant Products and Research Products. The Company's molecular diagnostics products were used for diagnosis of infectious diseases, blood screening, analyzing blood transfusions for immune response, testing coagulation pathways, and organ transplant viability. Their products and services also included technology and know-how in biomedical research and drug development.

 

Gen-Probe Incorporated is now part of Hologic Incorporated. Hologic and Gen-Probe have joined forces to create Hologic's diagnostics business. This business is dedicated to saving lives through early detection, improved diagnosis and less invasive treatment.

 

Hologic Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

 

Hologic Gen-Probe has nearly three decades of molecular diagnostics expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing molecular assays and systems that help safeguard the blood supply.

 

Hologic Gen-Probe is headquartered in San Diego.

 

Infectious Diseases

As a global leader in molecular diagnostics for infectious disease, Hologic Gen-Probe offers a broad range of products that use patented technologies to detect infectious microorganisms, including those causing sexually transmitted diseases (STDs), respiratory infectious diseases, tuberculosis, strep throat, pneumonia and fungal infections. Key products include the APTIMA assays to detect Chlamydia and gonorrhea, human papillomavirus, and Trichomonas vaginalis; and Prodesse assays that provide a wide range of molecular testing options for various types of respiratory disease and hospital-acquired infections.